Open-Angle Glaucoma Clinical Trial
Official title:
A Study of the Glaukos Trabecular Micro-Bypass Stent in Combination With Cataract Surgery in Open Angle Glaucoma Subjects.
Verified date | March 2016 |
Source | Glaukos Corporation |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to evaluate the safety and efficacy of the iStent trabecular micro-bypass stent in reducing intraocular pressure (IOP) in subjects with open-angle glaucoma or ocular hypertension and co-existing cataract.
Status | Completed |
Enrollment | 240 |
Est. completion date | March 2010 |
Est. primary completion date | July 2009 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Diagnosed with open-angle glaucoma (OAG) in the study eye. Pseudoexfoliative and pigmentary glaucoma are also acceptable diagnoses. - Subject on at least one glaucoma medication - Able and willing to attend follow up visits for two years post operative - Able and willing to sign informed consent Exclusion Criteria: - Prior glaucoma procedures (eg trabeculectomy, viscocanalostomy, ALT, SLT, shunt implant, collagen implant, cyclo destructive procedures etc) - Angle closure glaucoma - Fellow eye already enrolled |
Country | Name | City | State |
---|---|---|---|
United States | Williamson Nelson Eye Center | Baton Rouge | Louisiana |
United States | Southeast Texas Medical Association, L.L.P. | Beaumont | Texas |
United States | Assil Eye Institute | Beverly Hills | California |
United States | Florida Eye Microsurgical Institute, Inc. | Boynton Beach | Florida |
United States | Laurel Eye Center | Brookville | Pennsylvania |
United States | Cinicinnati Eye Institute | Cincinnati | Ohio |
United States | Kresge Eye Institute | Detroit | Michigan |
United States | Chu Vision Institute | Edina | Minnesota |
United States | Donald J. Digby and Associates | Greensboro | North Carolina |
United States | Discover Vision Centers | Independence | Missouri |
United States | Indiana University | Indianapolis | Indiana |
United States | Silverstein Eye Centers | Kansas City | Missouri |
United States | The Shepherd Eye Center | Las Vegas | Nevada |
United States | Glaucoma Consultants of Colorado | Littleton | Colorado |
United States | The Eye Care Institute Building | Louisville | Kentucky |
United States | The Center for Excellence in Eye Care | Miami | Florida |
United States | University of Minnesota | Minneapolis | Minnesota |
United States | Clayton Eye Center | Morrow | Georgia |
United States | Stiles Eyecare Excellence | Overland Park | Kansas |
United States | North Bay Eye Associates Inc | Petaluma | California |
United States | Wills Eye Hospital | Philadelphia | Pennsylvania |
United States | Associates in Ophthalmology | Pittsburgh | Pennsylvania |
United States | UPMC Eye Center | Pittsburgh | Pennsylvania |
United States | Mayo Clinic | Rochester | Minnesota |
United States | Ellison Ambulatory Care Center | Sacramento | California |
United States | Great Lakes Eye Care | Saint Joseph | Michigan |
United States | Harvard Eye Associates | San Clemente | California |
United States | Shepard Eye Center | Santa Maria | California |
United States | Glaucoma Consultants of Capital Region | Slingerlands | New York |
United States | International Eye Center | Tampa | Florida |
United States | James Branch MD | Winston-Salem | North Carolina |
Lead Sponsor | Collaborator |
---|---|
Glaukos Corporation |
United States,
Craven ER, Katz LJ, Wells JM, Giamporcaro JE; iStent Study Group. Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow-up. J Cataract Refract Surg. 2012 Aug;38 — View Citation
Samuelson TW, Katz LJ, Wells JM, Duh YJ, Giamporcaro JE; US iStent Study Group. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology. 2011 Mar;118(3):459-67. doi: 10.1016 — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Intraocular Pressure (Measured in mm Hg) Less or Equal to 21 mm Hg on no Topical Hypotensive Meds | Subjects with an intraocular pressure (IOP) less than or equal to 21 mm Hg without use of topical hypotensive medication at 12 months | 12 months | |
Secondary | Efficacy | Subjects with an intraocular pressure (IOP) reduction from baseline of greater than or equal to 20% without use of topical hypotensive medication at 12 months | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01157364 -
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
|
Phase 1/Phase 2 | |
Completed |
NCT02558374 -
Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension
|
Phase 3 | |
Completed |
NCT01415401 -
Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada
|
Phase 4 | |
Completed |
NCT01340014 -
Patient Preference Comparison of AZARGA Versus COSOPT
|
Phase 4 | |
Completed |
NCT01487655 -
Waveform Analysis of the Doppler Curve of Ophthalmic Arteries in Glaucoma Patients
|
N/A | |
Completed |
NCT01456390 -
Open-Angle Glaucoma Subjects With One Prior Trabeculectomy Treated Concurrently With One Suprachoroidal Stent and Two Trabecular Micro-bypass Stents
|
N/A | |
Completed |
NCT01444105 -
Open-angle Glaucoma Subjects on One Ocular Hypotensive Medication Randomized to Treatment With Two Trabecular Micro-bypass Stents or Selective Laser Trabeculoplasty
|
N/A | |
Completed |
NCT01426867 -
A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2%
|
Phase 2 | |
Completed |
NCT01455467 -
Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Randomized to Treatment With One or Two Trabecular Micro-bypass Stents in Conjunction With Cataract Surgery
|
N/A | |
Completed |
NCT01443988 -
Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent)or Travoprost
|
Phase 4 | |
Completed |
NCT01444040 -
Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost
|
Phase 4 | |
Completed |
NCT00759239 -
Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
|
Phase 4 | |
Completed |
NCT00397241 -
24-hour Study of Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combinations
|
Phase 4 | |
Completed |
NCT00273481 -
Cosopt Versus Xalacom
|
Phase 4 | |
Completed |
NCT00918346 -
Pharmacodynamics of Tafluprost 0.0015% Eye Drops: a Comparison Between the Preserved and Unpreserved Formulation
|
Phase 3 | |
Completed |
NCT00716742 -
Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG)
|
N/A | |
Completed |
NCT02558400 -
Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
|
Phase 3 | |
Withdrawn |
NCT03648229 -
African Glaucoma Laser Trial
|
Phase 4 | |
Completed |
NCT01978600 -
Evaluation of Intraocular Pressure Using Simbrinza™ in Patients With Open-Angle Glaucoma or Ocular Hypertension
|
Phase 4 | |
Completed |
NCT01699464 -
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
|
Phase 2 |